Bird Score
Ingredients
- Omega-3 Fatty Acids
- Omega-3 Polyunsaturated Fatty Acid
- Omega-3 Fatty Acid
- Omega-3
- Vitamin D And Omega-3 Fatty Acids Co-supplementation
- Vitamin B12 + Folic Acid + Omega-3 Fatty Acids
- Vitamin D And Omega-3 Fatty Acids
- Omega-3 Polyunsatuarted Fatty Acids
- Omega-3 Pufa
- Polyunsaturated Fatty Acids (pufa) Of The Omega 3 Series (n-3 Pufa: 18:3, N-3; 20:5, N-3; And 22:6, N-3), The Omega 6 Series (n-6 Pufa: 18:3, N-6), Vitamins And Minerals
- Omega‐3 Fatty Acids
- Omega 3 Fatty Acids
- Eicosapentaenoic Acid (epa; C20:5 N-3) And Docosahexaenoic Acid (dha; C22:6 N-3)
- Schistosoma Mansoni
- Dapagliflozin And Omega-3 (n-3) Carboxylic Acids
- Alpha-linolenic-acid (ala)
- Polyunsaturated Fatty Acids
- Fenugreek
- Omega-3 Pufa Plus Vitamin E (vit E)
- Omega-3 Polyunsaturated Fatty Acids
- Ephedra And Caffeine
- Omega-3 Fatty Acid Docosahexaenoic Acid (dha)
- Omega-3 Polyunsaturated Fatty Acids (n-3 Pufa)
Main Function
Nonalcoholic Fatty Liver Disease
Obesity
Non-alcoholic Fatty Liver Disease
Hypertension
Blood Glucose
Non-alcoholic Steatohepatitis
Fatigue
Skin
Urination
Immune
Diabetes
Blood Circulation
Hepatic Steatosis
Fatty Livers
Depressive
Non-alcoholic Fatty Liver Disease (nafld)
Fatty Liver
Cognition
Alcohol-induced Fatty Liver
Bioactive Compound
Type of Study
Mechanism Keyword
- Increasing The Expression Of Mfn2
- Implications For Reducing Oxidative Stress And Inflammation In Preeclampsia
- Appeared Safe And Effective In Causing Loss Of Weight And Body Fat, And Improving Several Metabolic Parameters, Including Insulin Sensitivity And Lipid Profiles
- Changes In Omega-3-toomega-6 Fatty Acid Ratio (pearson R = −0.45, P = 0.09) And Percent Eicosapentaenoic Acid (epa, Pearson R = −0.49, P = 0.07)
- Stat6-independent Mechanism
Top10 List (56) 버드 스코어링에 의한 리스트
| NO | Bird Score | Title |
|---|
 |
85.71 | Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-.. |
 |
84.14 | Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial |
 |
84.14 | Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial |
 |
82.71 | Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic reso.. |
 |
82.71 | A High Omega-3 Fatty Acid Multinutrient Supplement Benefits Cognition and Mobility in Older Women: A Randomized, Double-blind, Placebo-controlled Pilot S.. |
 |
82.71 | Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic reso.. |
 |
82.14 | Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled t.. |
 |
81.29 | Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malig.. |
 |
81.29 | The efficacy of omega-3 supplementation for major depression: a randomized controlled trial |
 |
80.71 | Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial |
| 80.71 | Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis | |
| 80.71 | Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese pat.. | |
| 80.71 | Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis | |
| 80.71 | Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial | |
| 79.86 | Effects of omega-3 fatty acids in hypertriglyceridemic states | |
| 79.86 | Effects of omega-3 fatty acids in hypertriglyceridemic states | |
| 79.29 | Protective Effects of Omega-3 Fatty Acids Supplementation Against Renal Parenchymal Scarring in Children with Acute Pyelonephritis: Results of a Pilot Cl.. | |
| 79.29 | The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes | |
| 79.29 | Protective Effects of Omega-3 Fatty Acids Supplementation Against Renal Parenchymal Scarring in Children with Acute Pyelonephritis: Results of a Pilot Cl.. | |
| 79.29 | Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized.. | |
| 79.29 | The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes | |
| 79.29 | Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial | |
| 79.29 | The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes | |
| 78.43 | Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malig.. | |
| 77.86 | Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment.. | |
| 74.29 | The combined effect of vitamin C and omega-3 polyunsaturated fatty acids on fatigue following coronary artery bypass graft surgery: a triple-blind clinic.. | |
| 72.86 | The effect of combined supplementation with vitamin D and omega-3 fatty acids on blood glucose and blood lipid levels in patients with gestational diabet.. | |
| 72.86 | The effect of combined supplementation with vitamin D and omega-3 fatty acids on blood glucose and blood lipid levels in patients with gestational diabet.. | |
| 72.86 | The effect of combined supplementation with vitamin D and omega-3 fatty acids on blood glucose and blood lipid levels in patients with gestational diabet.. | |
| 61.21 | Mitochondrial dysfunction during in vitro hepatocyte steatosis is reversed by omega-3 fatty acid-induced up-regulation of mitofusin 2 | |
| 61.21 | Mitochondrial dysfunction during in vitro hepatocyte steatosis is reversed by omega-3 fatty acid-induced up-regulation of mitofusin 2 | |
| 58.89 | Inhibitory potential of omega-3 fatty and fenugreek essential oil on key enzymes of carbohydrate-digestion and hypertension in diabetes rats | |
| 55.32 | Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids | |
| 53.75 | Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic stroke | |
| 52.46 | Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis | |
| 52.46 | Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis | |
| 52.32 | Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor | |
| 52.32 | Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor | |
| 50.32 | Zingiber officinale extract and omega-3 fatty acids ameliorate endoplasmic reticulum stress in a nonalcoholic fatty liver rat model | |
| 50.32 | Zingiber officinale extract and omega-3 fatty acids ameliorate endoplasmic reticulum stress in a nonalcoholic fatty liver rat model | |
| 50.32 | Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis | |
| 50.32 | Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model | |
| 50.32 | Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis | |
| 50.32 | A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnan.. | |
| 50.32 | The helminth glycoprotein omega-1 improves metabolic homeostasis in obese mice through type 2 immunity-independent inhibition of food intake | |
| 50.32 | Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats | |
| 50.32 | Effect of evening primrose oil and ω-3 polyunsaturated fatty acids on the cardiovascular risk of celecoxib in rats | |
| 50.32 | Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats | |
| 50.32 | Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis | |
| 50.32 | Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model | |
| 50.32 | A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnan.. | |
| 48.89 | Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease | |
| 48.89 | Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease | |
| 48.89 | A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnan.. | |
| 43.89 | Increased plasma levels of palmitoleic acid may contribute to beneficial effects of Krill oil on glucose homeostasis in dietary obese mice | |
| 43.89 | Increased plasma levels of palmitoleic acid may contribute to beneficial effects of Krill oil on glucose homeostasis in dietary obese mice |
